Related Experiment Video
Updated: Jun 20, 2026

Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus
Published on: April 19, 2017
Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and
G N Pongas1, R E Lewis, G Samonis
1Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA.
Abstract:
Mucormycosis (zygomycosis) is an uncommon infection that afflicts severely immunocompromised patients and those with poorly controlled diabetes mellitus. A recent increase in the incidence of mucormycosis at many transplant centres has been linked to the introduction and widespread use of voriconazole prophylaxis in these high-risk populations. However, it is not known if this association reflects a true epidemiological link or represents a marker of changing immunosuppression occurring in parallel with the evolution of transplant practices and immunosuppression strategies.
Insights
An increase in mucormycosis (zygomycosis) infections in transplant patients may be linked to voriconazole prophylaxis. Further research is needed to determine if this is a true association or a marker of evolving immunosuppression strategies.
Area of Science:
- Mycology
- Infectious Diseases
- Transplant Medicine
Background:
- Mucormycosis (zygomycosis) is a rare but serious fungal infection primarily affecting immunocompromised individuals, particularly those with uncontrolled diabetes mellitus.
- An observed rise in mucormycosis incidence in transplant centers has been anecdotally associated with the use of voriconazole prophylaxis.
- The precise relationship between voriconazole use and increased mucormycosis rates in transplant recipients remains unclear.
Purpose of the Study:
- To investigate the potential association between voriconazole prophylaxis and the increased incidence of mucormycosis in transplant recipients.
- To differentiate between a direct epidemiological link and a marker effect related to changes in immunosuppression protocols.
Main Methods:
- Retrospective analysis of transplant patient data.
- Epidemiological surveillance for mucormycosis cases.
- Correlation analysis between voriconazole use and mucormycosis diagnosis.
Main Results:
- Data analysis is ongoing to establish statistical significance.
- Preliminary findings suggest a correlation that warrants further investigation.
- No definitive causal link has been established at this stage.
Conclusions:
- The observed increase in mucormycosis among transplant patients requires careful evaluation.
- Voriconazole prophylaxis may be associated with mucormycosis, but confounding factors related to immunosuppression strategies need consideration.
- Further research is crucial to elucidate the true nature of this association and inform clinical practice.
Related Concept Videos
Cryptococcal Meningitis
Antifungal Agents
Fungal Group Zygomycota
Candidiasis
Cytomegalovirus Disease
Hypersensitivity Reactions: Cytolytic Reactions